World High Life Plc (AQSE:LIFE) (OTCQB:WRHLF) is pleased to announce the appointment of international HempCBD executive, Mr. Ross Westbrook, as Advisor for North American growth and operations as the Company prepares to build upon its UK success.

In preparation for the launch of Love Hemp products in North American markets, World High Life has appointed Mr. Ross Westbrook to plan and implement the Company’s strategy and operations for expansion. Ross Westbrook is recognized a leader in the Hemp/CBD retail space in particular, processing and marketing CBD products for nationally recognized brands such as Lazarus Naturals and Select (Social) CBD, Panacea Life Sciences, Luxe CBD, Infinite CBD, Pure Hemp Botanicals, Pharm CBD, Wink-wink and Paradise Candy.


Ross Westbrook Appointment Highlights

  • Mr. Ross Westbrook Appointed as Advisor for North American Growth and Operations
  • Recently served a term as Treasurer of the California Hemp Council – Sacramento, Ca.
  • CEO of Canamo Genetics
  • Founding member of Hemptown USA, and served as COO
  • Regional Sales Executive and Distributor for Panacea Life Sciences
  • Purveyor of CBD products at Transcend Canna in California carrying 11 product lines
  • Founded eFruit in 2011 and sold to Private Equity Group in 2015 with $20+ million in sales worldwide
  • Founded Primavera Marketing and served as their President for 22 years selling the company in 2010 with sales in excess of $200 million worldwide
  • Masters in International Business

Mr. Westbrook has more than 35 years in farming and marketing specialized agriculture-based items world-wide. He has implemented specialized marketing campaigns over the years to Costco in both the United States and Asia, and to Safeway, Kroger, Walmart and Whole Foods. He also has extensive experience marketing globally to Aeon, Lotte, Shinshegae, Marks & Spencer, Waitrose, Sainsburys, Alibaba derivatives, Coles, Woolworths and Cold Storage. Ross has exported or sold products to more than 33 different countries and has opened and managed sales offices in Hong Kong, Tokyo and Santiago, Chile.

“The Love Hemp Brand and product line continue to grow in the UK with strong consumer support, and our team has recognized the significant opportunity that exists to expand to North America as the next step in achieving our objective of making Love Hemp a global brand,” said Mr. David Stadnyk, World High Life Founder and CEO. “We are thrilled that Ross is now part of the World High Life team, his knowledge and experience in this industry combined with his network allow us to advance our business plan expediently, establishing a strong foundation for success going forward.”

“My experience in the industry has informed my belief that novel cannabinoids will be combined with traditional holistic plant materials that have been used medicinally for centuries,” said Mr. Westbrook. “The minute that I realized both David Stadnyk, WHL Founder and CEO, and Tony Calamita, Founder and CEO of Love Hemp, were of a similar mindset I knew that together, we had a unique and exciting opportunity to benefit people searching for innovative and effective health and wellness solutions. The addition of Love Hemp’s recently appointed Scientific Advisors further cemented the commitment to our shared vision. Every stop along my Hemp/CBD journey has been a stepping-stone to reach World High Life.”

For further information please contact:

David Stadnyk

Founder & CEO

North America: 1 (236) 521-7211

North America toll-free: 1 (888) 616-WRHLF (9745)

+44 (0) 7926 397 675

info@worldhighlife.uk

AQSE Corporate Adviser

Mark Anwyl/Allie Feuerlein

Peterhouse Capital Limited

+44 (0) 20 7469 0930

ma@peterhousecap.com

af@peterhousecap.com

Financial PR

Camilla Horsfall/Megan Ray

Blytheweigh

+44 (0) 20 7138 3224

Camilla.horsfall@blytheweigh.com

Megan.Ray@blytheweigh.com

For more information on World High Life please visit: www.worldhighlife.uk

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward Looking Information

We seek safe harbour. Some statements contained in this news release are “forward looking information” within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management’s current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: World High Life PLC

View source version on accesswire.com:
https://www.accesswire.com/595179/World-High-Life-PLC-Announces-Appointment-of-Advisor-for-North-America-Operations

ACCESSWIRE
June 24, 2020 – 11:00 PM PDT
News by QuoteMedia

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less